drugset / Trial / NCT01795183

Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia

NCT01795183

Phase 4 Completed 316 enrolled Sanofi
NaSingle-groupOpen-labelTreatment

Summary

Primary Objective: To evaluate the effectiveness of amisulpride in Chinese patients with schizophrenia Secondary Objective: To evaluate the overall safety of amisulpride in Chinese patients with schizophrenia.

Timeline

Start
2012-11
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Amisulpride Small molecule Oral

Indications